Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome
暂无分享,去创建一个
J. Farrar | T. Hien | C. Simmons | G. Thwaites | N. Dung | N. Lan | E. Torok | T. Chau | N. Quyen | N. D. Bang | D. Hoang | Dang Minh Hoang | H. Quy | P. P. Mai
[1] J. Farrar,et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. , 2005, The Journal of infectious diseases.
[2] A. Tunkel. Dexamethasone for treatment of tuberculous meningitis in adolescents and adults , 2005, Current infectious disease reports.
[3] J. Farrar,et al. The Clinical Benefit of Adjunctive Dexamethasone in Tuberculous Meningitis Is Not Associated with Measurable Attenuation of Peripheral or Local Immune Responses1 , 2005, The Journal of Immunology.
[4] N. H. Duc,et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. , 2005, The Journal of infectious diseases.
[5] Ajit Lalvani,et al. Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study , 2004, The Lancet.
[6] Priscille Brodin,et al. ESAT-6 proteins: protective antigens and virulence factors? , 2004, Trends in microbiology.
[7] P. López-Saura,et al. Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study , 2004, BMC infectious diseases.
[8] L. Fabbri,et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. , 2004, American journal of respiratory and critical care medicine.
[9] S. Cole,et al. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. , 2004, The Journal of infectious diseases.
[10] J. Farrar,et al. Improving the Bacteriological Diagnosis of Tuberculous Meningitis , 2004, Journal of Clinical Microbiology.
[11] J. Farrar,et al. Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis. , 2003, The Journal of infectious diseases.
[12] J. Deeks,et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.
[13] J. Deeks,et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.
[14] H. Vordermeier,et al. Use of Synthetic Peptides Derived from the Antigens ESAT-6 and CFP-10 for Differential Diagnosis of Bovine Tuberculosis in Cattle , 2001, Clinical Diagnostic Laboratory Immunology.
[15] J. Farrar,et al. Identification of a Matrix-Degrading Phenotype in Human Tuberculosis In Vitro and In Vivo1 , 2001, The Journal of Immunology.
[16] A. Hill,et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. , 2001, The Journal of infectious diseases.
[17] S. Katrak,et al. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection , 2000, Journal of the Neurological Sciences.
[18] I. Orme,et al. Interleukin-6 Induces Early Gamma Interferon Production in the Infected Lung but Is Not Required for Generation of Specific Immunity to Mycobacterium tuberculosisInfection , 2000, Infection and Immunity.
[19] R. Young,et al. Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system , 1999 .
[20] M. Jordana,et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.
[21] V. Vullo,et al. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. , 1997, Clinical immunology and immunopathology.
[22] W. Rom,et al. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol , 1997, The Lancet.
[23] K. Olsen,et al. Concentrations of Interferon γ, Tumor Necrosis Factor α, and Interleukin-1β in the Cerebrospinal Fluid of Children Treated for Tuberculous Meningitis , 1995 .
[24] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[25] H. Saito. Pathogenesis of tuberculous meningitis. , 1956, Acta tuberculosea Japonica.
[26] S. J. Shane,et al. Tuberculous meningitis: combined therapy with cortisone and antimicrobial agents. , 1953, The New England journal of medicine.
[27] Streptomycin in Tuberculosis Trials Commitee. STREPTOMYCIN treatment of tuberculous meningitis. , 1948, Lancet.
[28] P. Klenerman,et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] H. Akalın,et al. Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. , 1994, Scandinavian journal of infectious diseases.
[30] J. Van Snick. Interleukin-6: an overview. , 1990, Annual review of immunology.
[31] I. Cathie,et al. Streptomycin in the Treatment of Tuberculous Meningitis , 1950 .